tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Income Statement

Compare
418 Followers

ARS Pharmaceuticals Income Statement

Last quarter (Q1 2025), ARS Pharmaceuticals's total revenue was $7.97M, an increase of Infinity% from the same quarter last year. In Q1, ARS Pharmaceuticals's net income was $-33.94M. See ARS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 89.15M$ 30.00K$ 1.32M$ 5.51M$ 17.84M
Gross Profit
$ 88.17M$ 30.00K$ -16.00M$ -14.77M$ 3.77M
Operating Expenses
$ 91.25M$ 67.55M$ 36.83M$ 24.96M$ 18.30M
Depreciation and Amortization
$ 208.00K$ 73.00K$ 319.00K$ 213.00K$ 1.71M
EBITDA
$ -2.88M$ -67.45M$ -35.52M$ -19.24M$ -463.00K
Operating Income
$ -3.08M$ -67.52M$ -35.52M$ -19.45M$ -469.00K
Other Income/Expenses
$ 11.37M$ 13.15M$ 834.00K$ -789.00K$ -596.00K
Pretax Income
$ 8.29M$ -54.37M$ -34.68M$ -20.24M$ -1.06M
Net Income
$ 8.00M$ -54.37M$ -33.99M$ -20.24M$ -1.06M
Per Share Metrics
Basic EPS
$ 0.08$ -0.57$ -0.85$ -0.70$ -0.03
Diluted EPS
$ 0.08$ -0.57$ -0.85$ -0.70$ -0.03
Weighted Average Shares Outstanding
96.94M 95.22M 39.96M 28.87M 34.70M
Weighted Average Shares Outstanding (Diluted)
102.39M 95.22M 39.96M 28.87M 34.70M
Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis